[Thyroid function in prophylactic therapy with lithium (author's transl)].
In 62 out-patients under maintenance treatment with lithium, thyroid function was evaluated. 21% of the patients exhibited goiter II0; 34% showed elevated thyrotrophin (TSH) serum levels; in 42% exaggerated TSH response to intravenous thyrotrophin releasing hormone (TRH) was found.
D000328:Adult; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects*; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone / Q000097:blood; D013997:Time Factors
D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D008094:Lithium
Schiddrüsenfunktion bei der Lithiumprophylaxe.